Terms: = Bone cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715 AND Treatment
46 results:
1. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract] [Full Text] [Related]
2. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
Mai S; Hodges A; Chen HM; Zhang J; Wang YL; Liu Y; Nakatsu F; Wang X; Fang J; Xu Y; Davidov V; Kang K; Pingali SR; Ganguly S; Suzuki M; Konopleva M; Prinzing B; Zu Y; Gottschalk S; Lu Y; Chen SH; Pan PY
Cancer Res; 2023 Dec; 83(24):4047-4062. PubMed ID: 38098451
[TBL] [Abstract] [Full Text] [Related]
3. The role of minimally invasive surgery within a multidisciplinary approach for patients with metastatic spine disease over a decade: A systematic review.
Schupper AJ; Patel S; Steinberger JM; Germano IM
Neuro Oncol; 2024 Mar; 26(3):417-428. PubMed ID: 37988270
[TBL] [Abstract] [Full Text] [Related]
4. Novel insights into the pharmacological modulation of human periodontal ligament stem cells by the amino-bisphosphonate Alendronate.
Di Vito A; Chiarella E; Sovereto J; Bria J; Perrotta ID; Salatino A; Baudi F; Sacco A; Antonelli A; Biamonte F; Barni T; Giudice A
Eur J Cell Biol; 2023 Dec; 102(4):151354. PubMed ID: 37604089
[TBL] [Abstract] [Full Text] [Related]
5. DNA methylation landscape reveals LIN7A as a decitabine-responsive marker in patients with t(8;21) acute myeloid leukemia.
He S; Li Y; Shi X; Wang L; Cai D; Zhou J; Yu L
Clin Epigenetics; 2023 Mar; 15(1):37. PubMed ID: 36864492
[TBL] [Abstract] [Full Text] [Related]
6. High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma.
Chen Y; Cai Q; Chang Y; Zhang M; Li Z
Front Immunol; 2022; 13():1047115. PubMed ID: 36618391
[TBL] [Abstract] [Full Text] [Related]
7. Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
Stahl M; Derkach A; Farnoud N; Bewersdorf JP; Robinson T; Famulare C; Cho C; Devlin S; Menghrajani K; Patel MA; Cai SF; Miles LA; Bowman RL; Geyer MB; Dunbar A; Epstein-Peterson ZD; McGovern E; Schulman J; Glass JL; Taylor J; Viny AD; Stein EM; Getta B; Arcila ME; Gao Q; Barker J; Shaffer BC; Papadopoulos EB; Gyurkocza B; Perales MA; Abdel-Wahab O; Levine RL; Giralt SA; Zhang Y; Xiao W; Pai N; Papaemmanuil E; Tallman MS; Roshal M; Goldberg AD
Am J Hematol; 2023 Jan; 98(1):79-89. PubMed ID: 36251406
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Significance of MAP-7 and FOXC1 in Egyptian Acute Myeloid Leukemia Patients.
Nabawy SM; Refaat LA; Naser-Aldin HM; Rashed RA
Asian Pac J Cancer Prev; 2022 May; 23(5):1619-1626. PubMed ID: 35633546
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels.
Lopez de Lapuente Portilla A; Ekdahl L; Cafaro C; Ali Z; Miharada N; Thorleifsson G; Žemaitis K; Lamarca Arrizabalaga A; Thodberg M; Pertesi M; Dhapola P; Bao E; Niroula A; Bali D; Norddahl G; Ugidos Damboriena N; Sankaran VG; Karlsson G; Thorsteinsdottir U; Larsson J; Stefansson K; Nilsson B
Blood; 2022 Mar; 139(11):1659-1669. PubMed ID: 35007327
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
[TBL] [Abstract] [Full Text] [Related]
11. CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.
Guolo F; Fianchi L; Minetto P; Clavio M; Gottardi M; Galimberti S; Rizzuto G; Rondoni M; Bertani G; Dargenio M; Bilio A; Scappini B; Zappasodi P; Scattolin AM; Grimaldi F; Pietrantuono G; Musto P; Cerrano M; D'Ardia S; Audisio E; Cignetti A; Pasciolla C; Pavesi F; Candoni A; Gurreri C; Morselli M; Alati C; Fracchiolla N; Rossi G; Caizzi M; Carnevale-Schianca F; Tafuri A; Rossi G; Ferrara F; Pagano L; Lemoli RM
Blood Cancer J; 2020 Oct; 10(10):96. PubMed ID: 33024084
[TBL] [Abstract] [Full Text] [Related]
12. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract] [Full Text] [Related]
13. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic cebpa mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.
Zhang Z; Xu Y; Jiang M; Kong F; Chen Z; Liu S; Li F
Cancer Biol Ther; 2020 Apr; 21(4):309-314. PubMed ID: 31959056
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract] [Full Text] [Related]
16. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract] [Full Text] [Related]
18. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Platzbecker U; Wong RS; Verma A; Abboud C; Araujo S; Chiou TJ; Feigert J; Yeh SP; Götze K; Gorin NC; Greenberg P; Kambhampati S; Kim YJ; Lee JH; Lyons R; Ruggeri M; Santini V; Cheng G; Jang JH; Chen CY; Johnson B; Bennett J; Mannino F; Kamel YM; Stone N; Dougherty S; Chan G; Giagounidis A
Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043
[TBL] [Abstract] [Full Text] [Related]
19. [AML treatment strategy based on cytogenetic abnormalities and somatic mutations].
Imai Y
Rinsho Ketsueki; 2015 Oct; 56(10):1932-41. PubMed ID: 26458431
[TBL] [Abstract] [Full Text] [Related]
20. Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.
Sivagnanalingam U; Balys M; Eberhardt A; Wang N; Myers JR; Ashton JM; Becker MW; Calvi LM; Mendler JH
PLoS One; 2015; 10(7):e0132375. PubMed ID: 26177509
[TBL] [Abstract] [Full Text] [Related]
[Next]
